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Abstract
Purpose We looked for herpes simplex virus types 1 and
2 (HSV-1 and HSV-2, respectively), varicella zoster virus
(VZV), Epstein–Barr virus (EBV) and cytomegalovirus
(CMV) DNA in Malawian adults with clinically suspected
meningitis.
Methods We collected cerebrospinal fluid (CSF) from
consecutive adults admitted with clinically suspected
meningitis to Queen Elizabeth Central Hospital (QECH),
Blantyre, Malawi, for a period of 3 months. Those with
proven bacterial or fungal meningitis were excluded. Real-
time polymerase chain reaction (PCR) was performed on
the CSF for HSV-1 and HSV-2, VZV, EBV and CMV
DNA.
Results A total of 183 patients presented with clinically
suspected meningitis. Of these, 59 (32 %) had proven
meningitis (bacterial, tuberculous or cryptococcal), 39
(21 %) had normal CSF and 14 (8 %) had aseptic menin-
gitis. For the latter group, a herpes virus was detected in 9
(64 %): 7 (50 %) had EBV and 2 (14 %) had CMV, all
were human immunodeficiency virus (HIV)-positive. HSV-
2 and VZV were not detected. Amongst those with a nor-
mal CSF, 8 (21 %) had a detectable herpes virus, of which
7 (88 %) were HIV-positive.
Conclusions The spectrum of causes of herpes viral
meningitis in this African population is different to that in
Western industrialised settings, with EBV being frequently
detected in the CSF. The significance of this needs further
investigation.
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Introduction
In African settings, aseptic meningitis is thought to be
common, but the aetiology is rarely identified and there
have been few studies examining this question [1, 2]. In
industrialised countries where a more thorough diagnostic
work-up is possible, up to 50 % of cases have been found
to have a viral cause [3, 4].
Reactivation of herpes simplex virus (HSV) types 1 and
2, varicella zoster virus (VZV), Epstein–Barr virus (EBV)
and cytomegalovirus (CMV) are common in the context of
human immunodeficiency virus (HIV) infection and HIV–
herpes virus co-infection has been linked with a more
severe disease course [5, 6]. Whilst all five viruses can
cause meningitis in HIV-infected adults, EBV infection is
more usually associated with central nervous system (CNS)
lymphoma, whilst CMV is more frequently the cause of
encephalitis, radiculitis or retinitis [5, 7–9].
In sub-Saharan Africa, very little is known about the
prevalence of HSV, VZV, EBV and CMV as causes of
aseptic meningitis in the context of HIV. We, therefore,
looked for HSV, VZV, EBV and CMV infections in Mal-
awian adults with clinically suspected meningitis, but
without evidence of bacterial or fungal infection.
Methods
Patients and CSF samples
This study was a sub-analysis of cerebrospinal fluid (CSF)
from a cohort of adults (C16 years of age) with clinically
suspected meningitis admitted to Queen Elizabeth Central
Hospital (QECH), Blantyre, Malawi, from September
through to December 2007 [10]. Demographics and clinical
information were collected using a standardised case
record form. All persons gave their informed consent prior
to inclusion in the study. Routine microscopy and culture
of the CSF was performed and patients with microbiolog-
ically confirmed bacterial, cryptococcal or tuberculous
meningitis were excluded, as were those with probable
bacterial meningitis (CSF white cell polymorphs
[100 cells per mm3). Patients with a diagnosis of a CNS
infection within the last month were also excluded; this
was primarily done to ensure that our cohort of patients had
new clinical events and to avoid selecting those with a
relapse of past CNS infection. Patients with C5 white cells
per mm3 of CSF were defined as having an aseptic men-
ingitis, whilst those with \5 white cells per mm3 were
defined as not having meningitis using a laboratory diag-
nostic criteria [11]. A CD4 count of\200 cells/ll was used
to define advanced HIV disease.
The study was approved by the local ethics committee at
the College of Medicine, University of Malawi, Blantyre,
Malawi (P05/06/471) and the ethics committee medical
faculty, University Heidelberg, Heidelberg, Germany (S
026/2007).
Herpes virus detection
CSF samples were aliquoted and stored at -70 C prior to
molecular diagnostics for HSV, VZV, EBV and CMV. The
samples were tested as a batch at the time of this study.
DNA was extracted from 200 ll of CSF using a QIA-
amp DNA kit as per the manufacturer’s instructions. DNA
recovery was confirmed by spectroscopic analysis. We
used 5 ll of DNA for each polymerase chain reaction
(PCR) for the HSV, VZV and EBV assays, and 10 ll for
the CMV assay.
Primers and probes targeting conserved regions of the
DNA polymerase gene were used for HSV-1 (primer:
forward-GAC AGC GAA TTC GAG ATG CTG, reverse-
ATG TTG TAC CCG GTC ACG AAC T; probe: 50-FAM-
CAT GAC CCT TGT GAA ACA-MGB-30-BHQ1); HSV-2
(primer: same as HSV-1; probe: 50-VIC-TGA CCT TCG
TCA AGC AG-MGB-30-BHQ1) and VZV (primer: for-
ward-GCG CGG TAG TAA CAG AGA ATT TC, reverse-
ACG TGC ATG GAC CGG TTA AT; probe: 50-FAM-
ACC ATG TCA TCG TTT CAA-MGB-30-BHQ1). Simi-
larly, the tegument protein (BNFR1 gene) for EBV and
UL123/UL 55 genes for the CMV genome were targeted
[12, 13].
Applied Biosystems (ABI, UK) AmpliTaq Gold (29)
Master Mix was used for all the real-time PCR assays. All
reactions were carried out in the ABI 7300 real-time PCR
machine using 96-optical-well plates, with a total volume
of 25 ll per well. The PCR thermocycler conditions for all
assays included three stages; activation of UNG at 50 C
for 2 min, activation of Taq at 95 C for 15 min, followed
by amplification using 45 cycles at 95 C for 15 s and
60 C for 1 min.
A positive control (provided by the National Institute for
Biological Standards and Control, UK) for each herpes
virus was run with unknown specimens to ensure DNA
recovery. Similarly, specimens were processed in parallel
with aliquots of molecular-grade water to monitor for false-
positive results; the run was discarded if this was the case.
Each individual sample was processed in triplicate and the
sample was considered to be positive if two or more of the
three test results were positive. When only one out of the
three test results was positive, the PCR test was repeated
(n = 3) and the sample was then considered to be positive
if the test result was positive (n = 1). Quantification was
only performed with EBV and shown as genome copies per
millilitre of CSF. Serial dilution of 100–108 copies/ml of
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virus stock was used to obtain a standard curve with an
efficiency performance of 92 %. The concentration of EBV
genome in the samples was interpolated from this standard
curve.
VZV is known to have high genotype diversity [14]. To
ensure that the PCR primers were appropriate for VZV
strains circulating in Malawi, swabs (stored in viral med-
ium) taken from the vesicles of four patients with classical
shingles (vesicular rash in a dermatomal distribution) were
also analysed. The vesicular samples of all four patients
with shingles gave positive results.
A sensitivity analysis was performed to determine the
limit of detection using QCMD panels (Qnostics Ltd., UK).
We found the limit of detection to be 103 copies/ml or less
with each virus.
Statistical methods
The data were analysed using PASW Statistics 18, Release
Version 18.0.0 (O´ SPSS, Inc., 2009, Chicago, IL,
http://www.spss.com). Quantitative variables were expres-
sed as medians with interquartile ranges and qualitative
variables as frequencies and percentages. Fisher’s exact
test was used to compare categorical data and the Mann–
Whitney U test for continuous data; a p value of\0.05 was
taken to be statistically significant.
Results
A total of 183 patients presenting with clinically suspected
meningitis were identified over the 3-month study period.
Of these, 59 (32 %) had proven meningitis (bacterial,
tuberculous or cryptococcal), 39 (21 %) had normal CSF
and 14 (8 %) had an aseptic meningitis. In 48 (26 %)
patients, there was a relapse of a previous CNS infection
(Fig. 1). Thirty-six (68 %) of 53 patients with a normal or
aseptic CSF were HIV-positive, with a median CD4 count
of 159 mm3 (interquartile range 107–270 mm3).
Overall, in the aseptic meningitis group, a herpes virus
was detected in the CSF of 9/14 (64 %); all of them were
HIV-positive. Amongst those with a normal CSF, 8/39
(21 %) had a detectable herpes virus; of these, 7 (8 %)
were HIV-positive.
The prevalence of the individual herpes virus in those
with aseptic meningitis (14) was 7 (50 %) EBV and 2
Fig. 1 Flow diagram
describing the selection of
eligible participants and their
classification. CNS central
nervous system, CSF
cerebrospinal fluid, LP lumbar
puncture
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(14 %) CMV. In those with a normal CSF (39), 6 (15 %)
had EBV and 2 (5 %) had HSV-1 detected. No patient had
HSV-2 or VZV detected (Table 1).
When comparing the rate of detection in the HIV-
positive and HIV-negative patients, we found that only one
HIV-negative patient had a herpes virus detected in the
CSF (HSV-1), compared with 16 HIV-positive patients.
Thirteen (36 %) patients with HIV infection had EBV
detected in the CSF.
To investigate the relevance of the high EBV prevalence
found exclusively in the HIV-positive group, we explored
the relationship between CSF EBV titre, CSF white cell
count (WCC) and CD4 count. The median titre of EBV in
those with a normal CSF (\5 cells/mm3) was 1,202 copies/
ml, compared to 6,680 copies/ml in those with an abnormal
CSF (C5 cells/mm3) (p = 0.048). The median CSF EBV
titre in patients with advanced HIV infection was
2,223 copies/ml, compared with 1,239 copies/ml in those
with less advanced disease (p = 0.52).
Discussion
We have found that aseptic meningitis constituted 8 % of
the patients with clinically suspected meningitis in our
setting. Surprisingly, no HSV-2 or VZV DNA was detected
in the aseptic CSF; instead, we detected a high prevalence
of EBV and all of these patients were HIV-positive.
The prevalence of aseptic meningitis in our cohort was
lower than in Western industrialised countries, where
aseptic meningitis accounts for about 50 % of acute men-
ingitis [15]. As far as we know, there are only two other
publications which investigated aseptic meningitis in sub-
Saharan Africa; one in Zimbabwe found the frequency of
mononuclear meningitis to be 27 %, whilst the other in
South Africa found the frequency to be 59 %; neither
searched for viral aetiology [1, 2].
It is conceivable that the low frequency could be due to
an ascertainment bias, as patients with aseptic meningitis
have milder self-limiting disease and, therefore, do not
present to hospital. Alternatively, advanced HIV infection
might modulate the inflammatory response to viral infec-
tions in the CNS and, so, there is no pleocytosis. This might
be relevant to the 6 of 39 patients with normal CSF and
detectable EBV.
Our failure to detect HSV-2 and VZV in this cohort was
unexpected, since both are common identifiable causes of
viral meningitis in Western industrialised countries [16,
17]. It may be that the spectrum of causes of herpes viral
meningitis in a population with high HIV prevalence is
different to that in Western industrialised countries.
A striking finding was the high incidence of EBV in the
CSF of HIV-infected individuals, even in those with a
normal CSF. The presence of EBV in the CSF of people
with HIV is usually associated with primary CNS lym-
phoma rather than meningitis [5, 18]. It is impossible to
exclude the possibility that some of our patients may have
had lymphoma, as brain imaging or biopsy were not rou-
tinely available at the time of investigation, but the clinical
presentations of acute meningitis were very different to the
chronic altered mental status or focal neurological deficit,
which is usually seen in patients with CNS lymphoma [19].
The high detection of EBV in the CSF could be relevant
to the clinical presentation or it could reflect activation in
immunocompromised patients that is of no pathogenic
significance. However, the detection of EBV was signifi-
cantly higher in those with a raised CSF WCC. Ideally, we
would have liked to explore the association of EBV with
clinical outcome, but the retrospective nature of our study
limited this. We recently described an association with
high EBV titres in the CSF and poor outcome in patients
with bacterial meningitis, which suggests that there might
be more to this story [20].
In conclusion, we saw a different spectrum of herpes
virus infections in this population than that seen in Western
industrialised settings. EBV was frequently detected in the
CSF, regardless of whether there was a pleocytosis or not,
though higher viral titres were seen in patients with a
Table 1 Demographics, CSF characteristics and detection of herpes viruses in 53 patients with suspected viral meningitis
Aetiology Patients with virus
detected in CSF,
no. (%) (n = 53)
Males,
no. (%)
Age,
median (IQR)
HIV-positive,
no. (%)
CSF WCC,
cells/mm3,
median (IQR)
CSF protein mg/dl,
median (IQR)
HSV-1 2 (4) 2 (100) 35.5 (30, 41) 1 (50) 0 (0, 0) 36 (25, 52)
HSV-2 0 – – – – –
VZV 0 – – – – –
EBV 13 (25) 4 (31) 35 (28, 42) 13 (100) 17 (0, 310) 68 (46, 203)
CMV 2 (4) 0 35 (30, 40) 2 (100) 2140 (200, 4,080) 403 (278, 528)
No virus detected 36 (68) 15 (42) 35 (25, 40) 21 (58) 0 (0, 0) 36 (25, 52)
Any virus detected 17 (32) 6 (35) 33.5 (26, 42) 16 (94) 0 (0, 23) 50 (29, 72)
IQR interquartile range, WCC white cell count, CSF cerebrospinal fluid
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pleocytosis and in HIV-positive patients. The significance
of these findings merits further investigation.
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